Equillium

Last updated:

About Equillium (EQ)

Equillium, a clinical-stage biotechnology company, develops products to treat severe autoimmune and inflammatory disorders. Its lead product candidate, itolizumab (EQ001), a monoclonal antibody targeting CD6, is in Phase III trials for acute graft-versus-host disease and has completed Phase Ib trials for asthma and lupus nephritis. The company also develops EQ101 for cutaneous T cell lymphoma and alopecia areata, and EQ102 for gastrointestinal diseases.

Frequently asked questions

Is Equillium (EQ) stock halal to invest in?
As of , EQ is not Shariah-compliant and is therefore not considered a halal investment. This assessment is based on the data available in Equillium's most recent financial reports.
Does Equillium have any interest income?
Yes, Equillium does have interest income. According to the company's latest annual report for the fiscal year ending Dec 31, 2025, Equillium reported revenue of $0 and interest income of $833,000. The interest income represents 0% of the combined total. It's worth noting that some companies may report additional interest income as part of their revenue. For a detailed breakdown of all interest income and revenue segments, please refer to the full Shariah compliance report available in the Zoya app.
What guidelines are used to determine if Equillium stock is Shariah-compliant?
We use the guidelines set by the Accounting and Auditing Organization for Islamic Financial Institutions (AAOIFI) to assess Shariah compliance. AAOIFI is a leading international organization that establishes standards for Islamic finance. Their guidelines help determine if a company's business activities and financial structure align with Islamic principles. These standards are widely respected in the Islamic finance industry and provide a consistent framework for evaluating the Shariah compliance of stocks and other financial instruments. AAOIFI's Shariah board includes renowned scholars such as Sheikh Muhammad Taqi Usmani, Sheikh Mohamed Ali Elgari, Sheikh Abdullah AlManea, Sheikh Nizam Yaquby, and Dr. Aznan Hassan.
How often is Equillium stock reviewed for Shariah compliance?
The Shariah compliance status of Equillium stock is reviewed on a regular basis, with a minimum frequency of once per quarter. However, if there are any significant changes or major developments in the company's operations that may impact its compliance, an immediate review will be conducted to ensure ongoing adherence to Shariah principles.
How can I stay updated on Equillium's compliance status?
To stay informed, we recommend regularly checking Zoya for updates. You can also enable alerts within the Zoya app to receive notifications whenever there is a change in the Shariah compliance of EQ, or any other stocks you are monitoring. This is particularly useful as Shariah compliance can fluctuate due to changes in a company's financial ratios or business activities.
Are dividends from Equillium stock considered halal?
No, dividends from EQ are not considered halal because the stock is currently not Shariah-compliant. When a stock is non-compliant, any dividends received from it are considered impermissible income and should be donated to charity as a form of purification. To learn more about the purification process and how to handle impermissible income, read our comprehensive guide.
Do I need to pay Zakat on my Equillium shares?
If you hold Equillium stock as an investment, through an Employee Stock Ownership Plan (ESOP), stock options, restricted stock units (RSUs), or any other form of stock ownership, and meet the Nisab threshold, you may be required to pay Zakat on it. The calculation of Zakat on investments can be complex and depends on various factors. To help make this easy, we've created a free Zakat calculator for stocks. For a more seamless experience, use the Zoya mobile app, where you can link your brokerage account to automatically import holdings.

Community posts

Shariah compliance data powered by the Zoya API. Chart by TradingView
l10n-embeds